These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6255875)
61. Paxillin phosphorylation counteracts proteoglycan-mediated inhibition of axon regeneration. Kuboyama T; Luo X; Park K; Blackmore MG; Tojima T; Tohda C; Bixby JL; Lemmon VP; Kamiguchi H Exp Neurol; 2013 Oct; 248():157-69. PubMed ID: 23797153 [TBL] [Abstract][Full Text] [Related]
62. A transition path ensemble study reveals a linchpin role for Mg(2+) during rate-limiting ADP release from protein kinase A. Khavrutskii IV; Grant B; Taylor SS; McCammon JA Biochemistry; 2009 Dec; 48(48):11532-45. PubMed ID: 19886670 [TBL] [Abstract][Full Text] [Related]
63. Protein kinase from Mucor rouxii. Unshielding of new cyclic AMP binding sites upon dissociation of the ternary complex holoenzyme-cyclic AMP. Moreno S; Pastori R; Passeron S Mol Cell Biochem; 1983; 52(1):13-6. PubMed ID: 6306439 [TBL] [Abstract][Full Text] [Related]
64. Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Scott JD; Glaccum MB; Fischer EH; Krebs EG Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1613-6. PubMed ID: 3456605 [TBL] [Abstract][Full Text] [Related]
65. Biology of the protein kinase C family. O'Brian CA; Ward NE Cancer Metastasis Rev; 1989 Dec; 8(3):199-214. PubMed ID: 2697470 [TBL] [Abstract][Full Text] [Related]
66. Nuclear magnetic resonance studies of the conformation and kinetics of the peptide-substrate at the active site of bovine heart protein kinase. Granot J; Mildvan AS; Bramson HN; Thomas N; Kaiser ET Biochemistry; 1981 Feb; 20(3):602-10. PubMed ID: 7213597 [No Abstract] [Full Text] [Related]
67. Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Glass DB; Feller MJ; Levin LR; Walsh DA Biochemistry; 1992 Feb; 31(6):1728-34. PubMed ID: 1310617 [TBL] [Abstract][Full Text] [Related]
68. Conformational changes of type II regulatory subunit of cAMP-dependent protein kinase on cAMP binding. Johnson DR; Wong SS FEBS Lett; 1989 Apr; 247(2):480-2. PubMed ID: 2541025 [TBL] [Abstract][Full Text] [Related]
69. The kinetics of association of cyclic AMP to the two types of binding sites associated with protein kinase II from bovine myocardium. Ogreid D; Døskeland SO FEBS Lett; 1981 Jul; 129(2):287-92. PubMed ID: 6269882 [No Abstract] [Full Text] [Related]
70. Studies of the mechanism of action and regulation of cAMP-dependent protein kinase. Granot J; Mildvan AS; Kaiser ET Arch Biochem Biophys; 1980 Nov; 205(1):1-17. PubMed ID: 6255875 [No Abstract] [Full Text] [Related]
71. [Cyclic nucleotide-dependent protein kinases--the enzymological aspects and roles in the biological system (author's transl)]. Miyamoto E Tanpakushitsu Kakusan Koso; 1973 May; 18(5):321-32. PubMed ID: 4354861 [No Abstract] [Full Text] [Related]
72. Conformations and arrangement of substrates at active sites of ATP-utilizing enzymes. Mildvan AS Philos Trans R Soc Lond B Biol Sci; 1981 Jun; 293(1063):65-74. PubMed ID: 6115425 [TBL] [Abstract][Full Text] [Related]
73. Substrate diversity of the cAMP-dependent protein kinase: regulation based upon multiple binding interactions. Walsh DA; Glass DB; Mitchell RD Curr Opin Cell Biol; 1992 Apr; 4(2):241-51. PubMed ID: 1599690 [TBL] [Abstract][Full Text] [Related]
74. Kinetic and catalytic mechanisms of protein kinases. Adams JA Chem Rev; 2001 Aug; 101(8):2271-90. PubMed ID: 11749373 [No Abstract] [Full Text] [Related]